Thalidomide to Chemotherapy Related Nausea and Vomiting in Pancreatic Cancer
Status:
Recruiting
Trial end date:
2026-11-30
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the efficacy of thalidomide on improving the quality
of life for metastatic pancreatic cancer patients receiving gemcitabine and nab-paclitaxel
chemotherapy.